| Name | Anbio Biotechnology |
|---|---|
| CIK | 0001982708 |
| Tickers | NNNN |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | Non-accelerated filer<br>Emerging growth company |
| SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | 4916096247281 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
43 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | F-3ASR | AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU | 0001185185-26-002869 | 333-297349 | 261166035 | 33 | 2143027 | 1 | 1 | |
| 2026-06-12 | 3 | xslF345X06/ownership.xml | 0001185185-26-002487 | 3180 | ||||||
| 2026-06-12 | 3 | xslF345X06/ownership.xml | 0001185185-26-002486 | 3164 | ||||||
| 2026-05-19 | 6-K | FORM 6-K | 0001185185-26-001897 | 001-42526 | 26995746 | 34 | 426952 | |||
| 2026-04-27 | 6-K | FORM 6-K | 0001185185-26-001504 | 001-42526 | 26901448 | 34 | 761656 | |||
| 2026-04-09 | 20-F/A | FORM 20-F/A1 | 0001185185-26-001313 | 001-42526 | 26849720 | 34 | 274842 | 1 | 1 | |
| 2026-04-08 | 3 | xslF345X06/ownership.xml | 0001185185-26-001311 | 3162 | ||||||
| 2026-04-08 | 3 | xslF345X06/ownership.xml | 0001185185-26-001310 | 3174 | ||||||
| 2026-04-08 | 3 | xslF345X06/ownership.xml | 0001185185-26-001308 | 3168 | ||||||
| 2026-04-08 | 3 | xslF345X06/ownership.xml | 0001185185-26-001307 | 3165 | ||||||
| 2026-04-08 | 3 | xslF345X06/ownership.xml | 0001185185-26-001306 | 3153 | ||||||
| 2026-04-07 | 20-F | FORM 20-F | 0001185185-26-001294 | 001-42526 | 26845105 | 34 | 4222023 | 1 | 1 | |
| 2026-02-17 | 6-K | FORM 6-K | 0001185185-26-000588 | 001-42526 | 26642240 | 34 | 63583 | |||
| 2026-01-26 | 6-K | FORM 6-K | 0001185185-26-000269 | 001-42526 | 26558374 | 34 | 45734 | |||
| 2025-12-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-126654 | 001-42526 | 251614654 | 34 | 53660 | |||
| 2025-11-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-109447 | 001-42526 | 251474884 | 34 | 30888 | |||
| 2025-04-28 | 20-F | ANNUAL REPORT | 0001213900-25-035802 | 001-42526 | 25876296 | 34 | 4623291 | 1 | 1 | |
| 2025-02-21 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-016129 | 001-42526 | 25652672 | 34 | 235790 | |||
| 2025-02-19 | 424B4 | PROSPECTUS | 0001213900-25-015001 | 333-284106 | 25637084 | 33 | 6246562 | |||
| 2025-02-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000497 | 333-284106 | 25637042 | 33 | 1750 | ||
| 2025-02-18 | CERT | 8A_Cert_NNNN.pdf | 0001354457-25-000115 | 001-42526 | 25633557 | 34 | 761258 | |||
| 2025-02-14 | CORRESP | filename1.htm | 0001213900-25-014006 | 8024 | ||||||
| 2025-02-14 | CORRESP | filename1.htm | 0001213900-25-014005 | 6442 | ||||||
| 2025-02-14 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-013885 | 001-42526 | 25624386 | 34 | 14516 | |||
| 2025-02-10 | F-1/A | REGISTRATION STATEMENT | 0001213900-25-011623 | 333-284106 | 25604672 | 33 | 163247 | |||
| 2025-01-24 | F-1/A | REGISTRATION STATEMENT | 0001213900-25-006373 | 333-284106 | 25552811 | 33 | 169670 | |||
| 2025-01-22 | FWP | FREE WRITING PROSPECTUS | 0001213900-25-005105 | 333-284106 | 25543464 | 34 | 20515769 | |||
| 2025-01-10 | F-1/A | REGISTRATION STATEMENT | 0001213900-25-002551 | 333-284106 | 25522207 | 33 | 6749177 | |||
| 2024-12-31 | F-1 | REGISTRATION STATEMENT | 0001213900-24-114129 | 333-284106 | 241593804 | 33 | 7536728 | |||
| 2024-12-11 | DRSLTR | filename1.htm | 0001213900-24-107617 | 21284 | ||||||
| 2024-12-11 | DRS/A | filename1.htm | 0001213900-24-107614 | 377-07031 | 241540054 | 33 | 6452764 | |||
| 2024-12-04 | UPLOAD | filename1.pdf | 0000000000-24-013358 | 377-07031 | 46495 | |||||
| 2024-11-18 | DRS/A | filename1.htm | 0001213900-24-099679 | 377-07031 | 241472030 | 33 | 6457648 | |||
| 2024-07-01 | DRSLTR | filename1.htm | 0001213900-24-057662 | 12941 | ||||||
| 2024-07-01 | DRS/A | filename1.htm | 0001213900-24-057659 | 377-07031 | 241089116 | 33 | 5287621 | |||
| 2024-06-21 | UPLOAD | filename1.pdf | 0000000000-24-007087 | 377-07031 | 45643 | |||||
| 2024-06-10 | DRS/A | filename1.htm | 0001213900-24-050933 | 377-07031 | 241031364 | 33 | 5388487 | |||
| 2024-06-07 | DRSLTR | filename1.htm | 0001213900-24-050934 | 108086 | ||||||
| 2024-03-22 | UPLOAD | filename1.pdf | 0000000000-24-003186 | 377-07031 | 75229 | |||||
| 2024-03-11 | DRS/A | filename1.htm | 0001213900-24-021163 | 377-07031 | 24736253 | 33 | 6181479 | |||
| 2024-03-08 | DRSLTR | filename1.htm | 0001213900-24-021166 | 88676 | ||||||
| 2024-01-23 | UPLOAD | filename1.pdf | 0000000000-24-000910 | 377-07031 | 93627 | |||||
| 2023-12-27 | DRS | filename1.htm | 0001213900-23-098831 | 377-07031 | 231517689 | 33 | 6100369 |
One latest value per concept from companyfacts (81 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 0 | 2026-07-03 | F-3ASR | 2026-07-09 | 0001185185-26-002869 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0 | 2026-07-03 | F-3ASR | 2026-07-09 | 0001185185-26-002869 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 0 | 2026-07-03 | F-3ASR | 2026-07-09 | 0001185185-26-002869 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-07-03 | F-3ASR | 2026-07-09 | 0001185185-26-002869 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 104,979 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 3.66M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 3.66M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AccruedPayrollTaxesCurrent | Accrued Payroll Taxes, Current | USD | 87,836 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 6.56M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | Assets | Assets | USD | 30.24M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 30.24M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 7.77M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 7.77M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -3.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | HKD | 500,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | CashUninsuredAmount | Cash, Uninsured Amount | USD | 7.35M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 387,440 | 2024-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 1,294 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 1,293 | 2023-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.147 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 0.147 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | FederalDepositInsuranceCorporationPremiumExpense | Federal Deposit Insurance Corporation Premium Expense | USD | 250,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 493,562 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | GrossProfit | Gross Profit | USD | 7.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 6.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 2.59M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -353,872 | 2023-01-01 | 2023-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -18,311 | 2022-01-01 | 2022-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -17,143 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 581,466 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 8.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 7,999 | 2022-01-01 | 2022-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 337,101 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 142,023 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | Liabilities | Liabilities | USD | 87,836 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 30.24M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 87,836 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 6.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -4.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -6.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 6.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 635,723 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 1.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 5.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 12,059 | 2023-01-01 | 2023-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 14.08M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 87,836 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 138 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 24,312 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 | |
| us-gaap | OtherReceivableAfterAllowanceForCreditLossNoncurrent | OtherReceivableAfterAllowanceForCreditLossNoncurrent | USD | 18,009 | 2023-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 948 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 282,550 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 35.47M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 19.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 607,072 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 606,124 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 7.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 35.80M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 15.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | -68,003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 201,305 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | 23.58M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 8.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | Revenues | Revenues | USD | 8.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 18,311 | 2022-01-01 | 2022-12-31 | 2024 | FY | 20-F | 2025-04-28 | 0001213900-25-035802 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 1.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 4.13M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 30.16M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 6.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 10,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationForfeited | Shares Issued, Value, Share-based Payment Arrangement, Forfeited | USD | 0 | 2023-01-01 | 2023-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 43.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 43.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-07 | 0001185185-26-001294 |